Aspiriant LLC Lowers Stock Holdings in CVS Health Co. (NYSE:CVS)

Aspiriant LLC trimmed its stake in CVS Health Co. (NYSE:CVS) by 10.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,287 shares of the pharmacy operator’s stock after selling 380 shares during the period. Aspiriant LLC’s holdings in CVS Health were worth $262,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Riverpoint Wealth Management Holdings LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $218,000. Canoe Financial LP raised its holdings in shares of CVS Health by 95.1% in the 4th quarter. Canoe Financial LP now owns 1,762,629 shares of the pharmacy operator’s stock valued at $139,177,000 after purchasing an additional 859,134 shares in the last quarter. Meritage Portfolio Management raised its holdings in shares of CVS Health by 30.6% in the 4th quarter. Meritage Portfolio Management now owns 66,322 shares of the pharmacy operator’s stock valued at $5,237,000 after purchasing an additional 15,548 shares in the last quarter. Ancora Advisors LLC raised its holdings in shares of CVS Health by 17.5% in the 3rd quarter. Ancora Advisors LLC now owns 457,267 shares of the pharmacy operator’s stock valued at $31,926,000 after purchasing an additional 68,005 shares in the last quarter. Finally, Forum Financial Management LP raised its holdings in shares of CVS Health by 19.4% in the 4th quarter. Forum Financial Management LP now owns 17,856 shares of the pharmacy operator’s stock valued at $1,410,000 after purchasing an additional 2,901 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on CVS. JPMorgan Chase & Co. reduced their price objective on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Truist Financial reiterated a “buy” rating and set a $66.00 price objective (down previously from $90.00) on shares of CVS Health in a research note on Thursday, May 2nd. Bank of America reduced their price objective on shares of CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a research note on Thursday, May 2nd. Piper Sandler boosted their price objective on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $58.00 price objective on shares of CVS Health in a research note on Wednesday, June 12th. Eleven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus price target of $75.05.

Insiders Place Their Bets

In other CVS Health news, Director Edward J. Ludwig acquired 1,000 shares of the stock in a transaction dated Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.24% of the stock is currently owned by insiders.

CVS Health Stock Performance

NYSE:CVS opened at $60.63 on Thursday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. The company has a fifty day moving average of $60.16 and a two-hundred day moving average of $70.45. The stock has a market capitalization of $76.11 billion, a PE ratio of 10.65, a P/E/G ratio of 0.58 and a beta of 0.53. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. CVS Health’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter last year, the company earned $2.20 earnings per share. As a group, research analysts forecast that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.